These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 28947795)
1. Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control. Kulaberoglu Y; Lin K; Holder M; Gai Z; Gomez M; Assefa Shifa B; Mavis M; Hoa L; Sharif AAD; Lujan C; Smith ESJ; Bjedov I; Tapon N; Wu G; Hergovich A Nat Commun; 2017 Sep; 8(1):695. PubMed ID: 28947795 [TBL] [Abstract][Full Text] [Related]
3. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer. Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378 [TBL] [Abstract][Full Text] [Related]
4. Structural basis for Mob1-dependent activation of the core Mst-Lats kinase cascade in Hippo signaling. Ni L; Zheng Y; Hara M; Pan D; Luo X Genes Dev; 2015 Jul; 29(13):1416-31. PubMed ID: 26108669 [TBL] [Abstract][Full Text] [Related]
5. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling. Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Protein Interactions by Xiong S; Couzens AL; Kean MJ; Mao DY; Guettler S; Kurinov I; Gingras AC; Sicheri F Mol Cell Proteomics; 2017 Jun; 16(6):1111-1125. PubMed ID: 28373297 [TBL] [Abstract][Full Text] [Related]
7. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling. Mana-Capelli S; McCollum D J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Chen M; Wang M; Xu S; Guo X; Jiang J Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204 [TBL] [Abstract][Full Text] [Related]
9. Structural Basis for Auto-Inhibition of the NDR1 Kinase Domain by an Atypically Long Activation Segment. Xiong S; Lorenzen K; Couzens AL; Templeton CM; Rajendran D; Mao DYL; Juang YC; Chiovitti D; Kurinov I; Guettler S; Gingras AC; Sicheri F Structure; 2018 Aug; 26(8):1101-1115.e6. PubMed ID: 29983373 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for autoinhibition and its relief of MOB1 in the Hippo pathway. Kim SY; Tachioka Y; Mori T; Hakoshima T Sci Rep; 2016 Jun; 6():28488. PubMed ID: 27335147 [TBL] [Abstract][Full Text] [Related]
11. Hippo Signaling in Mitosis: An Updated View in Light of the MEN Pathway. Hergovich A Methods Mol Biol; 2017; 1505():265-277. PubMed ID: 27826870 [TBL] [Abstract][Full Text] [Related]
12. Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway. Boggiano JC; Vanderzalm PJ; Fehon RG Dev Cell; 2011 Nov; 21(5):888-95. PubMed ID: 22075147 [TBL] [Abstract][Full Text] [Related]
13. The Roles of NDR Protein Kinases in Hippo Signalling. Hergovich A Genes (Basel); 2016 May; 7(5):. PubMed ID: 27213455 [TBL] [Abstract][Full Text] [Related]
14. TRIP6 inhibits Hippo signaling in response to tension at adherens junctions. Dutta S; Mana-Capelli S; Paramasivam M; Dasgupta I; Cirka H; Billiar K; McCollum D EMBO Rep; 2018 Feb; 19(2):337-350. PubMed ID: 29222344 [TBL] [Abstract][Full Text] [Related]
15. SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling. Mei L; Qv M; Bao H; He Q; Xu Y; Zhang Q; Shi W; Ren Q; Yan Z; Xu C; Tang C; Hussain M; Zeng LH; Wu X Oncogene; 2021 Sep; 40(35):5357-5366. PubMed ID: 34267330 [TBL] [Abstract][Full Text] [Related]
16. Structural and Biochemical Analyses of the Core Components of the Hippo Pathway. Ni L; Luo X Methods Mol Biol; 2019; 1893():239-256. PubMed ID: 30565138 [TBL] [Abstract][Full Text] [Related]
17. Oxidative stress-CBP axis modulates MOB1 acetylation and activates the Hippo signaling pathway. Jin J; Zhang L; Li X; Xu W; Yang S; Song J; Zhang W; Zhan J; Luo J; Zhang H Nucleic Acids Res; 2022 Apr; 50(7):3817-3834. PubMed ID: 35349706 [TBL] [Abstract][Full Text] [Related]
18. Protein kinases of the Hippo pathway: regulation and substrates. Avruch J; Zhou D; Fitamant J; Bardeesy N; Mou F; Barrufet LR Semin Cell Dev Biol; 2012 Sep; 23(7):770-84. PubMed ID: 22898666 [TBL] [Abstract][Full Text] [Related]
19. Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression. Quan M; Chen Z; Jiao F; Xiao X; Xia Q; Chen J; Chao Q; Li Y; Gao Y; Yang H; Wang L; Cui J J Exp Clin Cancer Res; 2020 Jan; 39(1):13. PubMed ID: 31941533 [TBL] [Abstract][Full Text] [Related]
20. Roles of mammalian sterile 20-like kinase 2-dependent phosphorylations of Mps one binder 1B in the activation of nuclear Dbf2-related kinases. Bao Y; Sumita K; Kudo T; Withanage K; Nakagawa K; Ikeda M; Ohno K; Wang Y; Hata Y Genes Cells; 2009 Dec; 14(12):1369-81. PubMed ID: 19919647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]